- Home
- FAMI vs QNRX Comparison
FAMI vs QNRX Comparison
Compare FAMI & QNRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FAMI
- QNRX
- Stock Information
- Founded
- FAMI 2015
- QNRX 2018
- Country
- FAMI China
- QNRX United States
- Employees
- FAMI N/A
- QNRX N/A
- Industry
- FAMI Packaged Foods
- QNRX Medical/Dental Instruments
- Sector
- FAMI Consumer Staples
- QNRX Health Care
- Exchange
- FAMI Nasdaq
- QNRX Nasdaq
- Market Cap
- FAMI 2.1M
- QNRX 2.5M
- IPO Year
- FAMI 2018
- QNRX N/A
- Fundamental
- Price
- FAMI $1.64
- QNRX $7.12
- Analyst Decision
- FAMI
- QNRX
- Analyst Count
- FAMI 0
- QNRX 0
- Target Price
- FAMI N/A
- QNRX N/A
- AVG Volume (30 Days)
- FAMI 96.1K
- QNRX 355.0K
- Earning Date
- FAMI 05-06-2025
- QNRX 05-08-2025
- Dividend Yield
- FAMI N/A
- QNRX N/A
- EPS Growth
- FAMI N/A
- QNRX N/A
- EPS
- FAMI N/A
- QNRX N/A
- Revenue
- FAMI $64,131,332.00
- QNRX N/A
- Revenue This Year
- FAMI N/A
- QNRX N/A
- Revenue Next Year
- FAMI N/A
- QNRX N/A
- P/E Ratio
- FAMI N/A
- QNRX N/A
- Revenue Growth
- FAMI N/A
- QNRX N/A
- 52 Week Low
- FAMI $1.43
- QNRX $5.01
- 52 Week High
- FAMI $11.28
- QNRX $54.95
- Technical
- Relative Strength Index (RSI)
- FAMI 40.76
- QNRX 46.54
- Support Level
- FAMI $1.55
- QNRX $5.27
- Resistance Level
- FAMI $1.98
- QNRX $7.22
- Average True Range (ATR)
- FAMI 0.14
- QNRX 1.12
- MACD
- FAMI 0.05
- QNRX 0.22
- Stochastic Oscillator
- FAMI 29.17
- QNRX 62.79
About FAMI Farmmi Inc.
Farmmi Inc is an investment holding company. Through its subsidiaries, it acts as a supplier of agricultural products. It is an agricultural technology enterprise focused on its supply chain platform by promoting edible mushroom products and agriculture technology. Its product offerings include tapioca, corn, red dates, shiitake mushrooms, mu er fungus, other edible fungi, and other agricultural products. Geographically, the company's products are sold in China, Southeast Asia, Japan, North America, Europe, and the Middle East under the Forasen and Farmmi brands.
About QNRX Quoin Pharmaceuticals Ltd.
Quoin Pharmaceuticals Ltd is a clinical stage specialty pharmaceutical company focused on developing and commercializing therapeutic products that treat rare and orphan diseases. Its pipeline comprises three products that collectively have the potential to target a broad number of rare and orphan indications, including Netherton Syndrome, Peeling Skin Syndrome, Palmoplantar Keratoderma, Epidermolysis Bullosa, and others.